Stock Events

Stock Events

Keros Therapeutics (KROS) Q4 2024 Earnings

Nov 6Confirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.41

-1.34

-1.28

-1.21

Details

Expected EPS

-1.278663

Actual EPS

-1.41

Surprise EPS

-0.13

Surprise Percent

-10.27%

Description

⁨Keros Therapeutics⁩ (⁦KROS⁩) has reported earnings of ⁦-1.41⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.